• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关氧化酶ERO1-α通过氧化折叠调节主要组织相容性复合体I类分子的表达。

Cancer-Associated Oxidase ERO1-α Regulates the Expression of MHC Class I Molecule via Oxidative Folding.

作者信息

Kukita Kazuharu, Tamura Yasuaki, Tanaka Tsutomu, Kajiwara Toshimitsu, Kutomi Goro, Saito Keita, Okuya Koichi, Takaya Akari, Kanaseki Takayuki, Tsukahara Tomohide, Hirohashi Yoshihiko, Torigoe Toshihiko, Furuhata Tomohisa, Hirata Koichi, Sato Noriyuki

机构信息

Department of Pathology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan; and Department of Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.

Department of Pathology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan; and

出版信息

J Immunol. 2015 May 15;194(10):4988-96. doi: 10.4049/jimmunol.1303228. Epub 2015 Apr 13.

DOI:10.4049/jimmunol.1303228
PMID:25870246
Abstract

ERO1-α is an oxidizing enzyme that exists in the endoplasmic reticulum and is induced under hypoxia. It reoxidizes the reduced form of protein disulfide isomerase that has oxidized target proteins. We found that ERO1-α is overexpressed in a variety of tumor types. MHC class I H chain (HC) has two disulfide bonds in the α2 and α3 domains. MHC class I HC folding is linked to the assembly of MHC class I molecules because only fully disulfide-bonded class I HCs efficiently assemble with β2-microglobulin. In this study, we show that ERO1-α associates with protein disulfide isomerase, calnexin, and immature MHC class I before being incorporated into the TAP-1-associated peptide-loading complex. Importantly, ERO1-α regulates the redox state as well as cell surface expression of MHC class I, leading to alteration of susceptibility by CD8(+) T cells. Similarly, the ERO1-α expression within cancer cells was associated with the expression level of MHC class I in colon cancer tissues. Thus, the cancer-associated ERO1-α regulates the expression of the MHC class I molecule via oxidative folding.

摘要

ERO1-α是一种存在于内质网中的氧化酶,在缺氧条件下被诱导表达。它能将已氧化靶蛋白的蛋白质二硫键异构酶的还原形式重新氧化。我们发现ERO1-α在多种肿瘤类型中过度表达。MHC I类重链(HC)在α2和α3结构域中有两个二硫键。MHC I类HC折叠与MHC I类分子的组装相关,因为只有完全形成二硫键的I类HC才能有效地与β2-微球蛋白组装。在本研究中,我们表明ERO1-α在被整合到与TAP-1相关的肽负载复合物之前,与蛋白质二硫键异构酶、钙连蛋白和未成熟的MHC I类相关。重要的是,ERO1-α调节MHC I类的氧化还原状态以及细胞表面表达,导致CD8(+) T细胞敏感性改变。同样,癌细胞内的ERO1-α表达与结肠癌组织中MHC I类的表达水平相关。因此,与癌症相关的ERO1-α通过氧化折叠调节MHC I类分子的表达。

相似文献

1
Cancer-Associated Oxidase ERO1-α Regulates the Expression of MHC Class I Molecule via Oxidative Folding.癌症相关氧化酶ERO1-α通过氧化折叠调节主要组织相容性复合体I类分子的表达。
J Immunol. 2015 May 15;194(10):4988-96. doi: 10.4049/jimmunol.1303228. Epub 2015 Apr 13.
2
Cancer-associated oxidoreductase ERO1-α drives the production of tumor-promoting myeloid-derived suppressor cells via oxidative protein folding.癌症相关氧化还原酶ERO1-α通过氧化蛋白折叠驱动促肿瘤髓源性抑制细胞的产生。
J Immunol. 2015 Feb 15;194(4):2004-10. doi: 10.4049/jimmunol.1402538. Epub 2015 Jan 16.
3
[Human endoplasmic reticulum oxidoreductin 1-like α regulates immune response of cancer cells via modulation of major histocompatibility complex class I expression and oxidation].[人类内质网氧化还原酶1样α通过调节主要组织相容性复合体I类表达和氧化来调控癌细胞的免疫反应]
Gan To Kagaku Ryoho. 2012 Nov;39(12):1800-2.
4
Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-α-mediated oxidative folding in murine tumor cells.缺氧通过促进 ERO1-α 介导的氧化折叠增强小鼠肿瘤细胞 MHC Ⅰ类抗原呈递。
Eur J Immunol. 2016 Dec;46(12):2842-2851. doi: 10.1002/eji.201646525. Epub 2016 Oct 18.
5
Role of the ERO1-PDI interaction in oxidative protein folding and disease.ERO1-PDI 相互作用在氧化蛋白折叠和疾病中的作用。
Pharmacol Ther. 2020 Jun;210:107525. doi: 10.1016/j.pharmthera.2020.107525. Epub 2020 Mar 20.
6
Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level.癌症相关氧化还原酶ERO1-α通过氧化蛋白折叠和调节mRNA水平驱动血管内皮生长因子(VEGF)的产生。
Br J Cancer. 2016 May 24;114(11):1227-34. doi: 10.1038/bjc.2016.105. Epub 2016 Apr 21.
7
Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer.癌症相关氧化还原酶ERO1-α通过上调人乳腺癌中PD-L1促进免疫逃逸。
Oncotarget. 2017 Apr 11;8(15):24706-24718. doi: 10.18632/oncotarget.14960.
8
A PDI-catalyzed thiol-disulfide switch regulates the production of hydrogen peroxide by human Ero1.一种由PDI催化的硫醇-二硫键转换调节人Ero1产生过氧化氢的过程。
Free Radic Biol Med. 2015 Jun;83:361-72. doi: 10.1016/j.freeradbiomed.2015.02.011. Epub 2015 Feb 17.
9
Reconstitution of human Ero1-Lalpha/protein-disulfide isomerase oxidative folding pathway in vitro. Position-dependent differences in role between the a and a' domains of protein-disulfide isomerase.体外重建人Ero1-Lalpha/蛋白质二硫键异构酶氧化折叠途径。蛋白质二硫键异构酶的a和a'结构域在作用上的位置依赖性差异。
J Biol Chem. 2009 Jan 2;284(1):199-206. doi: 10.1074/jbc.M806645200. Epub 2008 Nov 11.
10
The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha.细胞氧张力调节内质网氧化还原酶ERO1-Lα的表达。
Eur J Biochem. 2003 May;270(10):2228-35. doi: 10.1046/j.1432-1033.2003.03590.x.

引用本文的文献

1
ERO1α regulates colon cancer progression and 5-FU resistance through the miR-451a/ARF1 axis.ERO1α通过miR-451a/ARF1轴调节结肠癌进展和5-氟尿嘧啶耐药性。
Int J Colorectal Dis. 2025 Aug 21;40(1):184. doi: 10.1007/s00384-025-04987-7.
2
B4GALT5 inhibits CD8 T-cell response by downregulating MHC-I level through ERAD pathway in PDAC.B4GALT5通过内质网相关蛋白降解(ERAD)途径下调MHC-I水平,从而抑制胰腺导管腺癌(PDAC)中的CD8 T细胞反应。
J Immunother Cancer. 2025 May 2;13(5):e010908. doi: 10.1136/jitc-2024-010908.
3
Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients.
用于预测胃癌患者对PD-1抑制剂免疫治疗反应的蛋白质组学分析及生物标志物发现
Front Pharmacol. 2024 May 31;15:1349459. doi: 10.3389/fphar.2024.1349459. eCollection 2024.
4
Advances in reprogramming of energy metabolism in tumor T cells.肿瘤 T 细胞能量代谢重编程的研究进展。
Front Immunol. 2024 Feb 13;15:1347181. doi: 10.3389/fimmu.2024.1347181. eCollection 2024.
5
Inhibition of ERO1a and IDO1 improves dendritic cell infiltration into pancreatic ductal adenocarcinoma.抑制 ERO1a 和 IDO1 可改善树突状细胞浸润胰腺导管腺癌。
Front Immunol. 2023 Dec 22;14:1264012. doi: 10.3389/fimmu.2023.1264012. eCollection 2023.
6
Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer.结直肠癌中免疫治疗疗效的预测及缺氧的免疫调节作用
Ther Adv Med Oncol. 2022 Nov 19;14:17588359221138383. doi: 10.1177/17588359221138383. eCollection 2022.
7
Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells.缺氧对 HPV16 转化细胞的抗原呈递和基于 T 细胞的免疫识别的影响。
Front Immunol. 2022 Oct 21;13:918528. doi: 10.3389/fimmu.2022.918528. eCollection 2022.
8
Effects of autophagy-associated genes on the prognosis for lung adenocarcinoma.自噬相关基因对肺腺癌预后的影响。
Transl Cancer Res. 2020 Mar;9(3):1947-1959. doi: 10.21037/tcr.2020.02.07.
9
Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies.蛋白二硫键异构酶 A1 相关通路在分层乳腺癌治疗中的作用。
Int J Oncol. 2022 Feb;60(2). doi: 10.3892/ijo.2022.5306. Epub 2022 Jan 11.
10
Knockdown of PPARδ Induces VEGFA-Mediated Angiogenesis Interaction With ERO1A in Human Colorectal Cancer.敲低PPARδ可诱导人结直肠癌中VEGFA介导的血管生成并与ERO1A相互作用。
Front Oncol. 2021 Oct 12;11:713892. doi: 10.3389/fonc.2021.713892. eCollection 2021.